stockrow
Monday 9 November 2026
Export ADRX’s income statement to Excel — free account
ADARx Pharmaceuticals, Inc.
ADRX
13.23
0.06
−0.45%
Follow ADRX
Alert me
ADARx Pharmaceuticals, Inc. (ADRX) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NUVB Nuvation Bio Inc. compare | n/m |
| IMCR Immunocore Holdings PLC Sponsored ADR compare | n/m |
| NBTX Nanobiotix S.A. - Sponsored ADR compare | n/m |
| TYRA Tyra Biosciences, Inc. compare | n/m |
| QURE uniQure N.V. compare | n/m |
| OCUL Ocular Therapeutix, Inc. compare | n/m |
| PGEN Precigen, Inc. compare | 60.8× |
| AAPG Ascentage Pharma Group International - Unsponsored ADR compare | — |
| ADRX ADARx Pharmaceuticals, Inc. | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)